(Q34625439)

3 August 2017

title

Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

3 August 2017

0 references

0 references

author name string

Mariève Doucet

1

1 reference

3 August 2017

Aaron P Russell

2

1 reference

3 August 2017

Bertrand Léger

3

1 reference

3 August 2017

Richard Debigaré

4

1 reference

3 August 2017

Denis R Joanisse

5

1 reference

3 August 2017

Marc-André Caron

6

1 reference

3 August 2017

Pierre LeBlanc

7

1 reference

3 August 2017

François Maltais

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

3 May 2007

1 reference

American Journal of Respiratory and Critical Care Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

176

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

261-269

1 reference

Local and systemic inflammation in chronic obstructive pulmonary disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Catabolic/anabolic balance and muscle wasting in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Molecular determinants of skeletal muscle mass: getting the "AKT" together

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Skeletal muscle hypertrophy and atrophy signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Signal-transduction networks and the regulation of muscle protein degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

mTOR signaling and the molecular adaptation to resistance exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Invited Review: Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Skeletal muscle inflammation and nitric oxide in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

Systemic effects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-704OC

10.1164/RCCM.200605-704OC

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference